<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MolChord: Structure-Sequence Alignment for Protein-Guided Drug Design - Health AI Hub</title>
    <meta name="description" content="MolChord proposes a novel structure-sequence alignment approach for protein-guided drug design, integrating multi-modal representations (structural, sequential,">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>MolChord: Structure-Sequence Alignment for Protein-Guided Drug Design</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2510.27671v1" target="_blank">2510.27671v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-10-31
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Wei Zhang, Zekun Guo, Yingce Xia, Peiran Jin, Shufang Xie, Tao Qin, Xiang-Yang Li
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2510.27671v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2510.27671v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">MolChord proposes a novel structure-sequence alignment approach for protein-guided drug design, integrating multi-modal representations (structural, sequential, textual) to generate molecular ligands. It utilizes NatureLM as a molecule generator with a diffusion-based structure encoder, and refines drug properties through a preference-aware dataset and Direct Preference Optimization. The method achieves state-of-the-art performance on CrossDocked2020, highlighting its potential for practical drug discovery.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research directly impacts drug discovery by enabling the more efficient and precise design of novel molecular ligands tailored to specific protein targets, potentially accelerating the development of new therapeutic agents with optimized pharmacological profiles.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This research applies AI techniques (autoregressive models like NatureLM, diffusion models, Direct Preference Optimization) as a 'molecule generator' and 'practical tool for SBDD' to accelerate and improve the process of identifying and designing new drug candidates. This constitutes a direct application of AI to drug discovery, a critical area within medical AI.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses core challenges in Structure-based Drug Design (SBDD): aligning protein structural representations with molecular representations, and guiding generated drugs towards desired pharmacological properties.</li>
                    
                    <li>Introduces MolChord, which integrates two key techniques: multi-modal alignment and property-guided drug generation.</li>
                    
                    <li>Utilizes NatureLM, an autoregressive model unifying text, small molecules, and proteins, as the molecule generator to align structural, sequential (FASTA, SMILES), and textual descriptions.</li>
                    
                    <li>Employs a diffusion-based structure encoder for effective alignment of protein and molecule structural representations.</li>
                    
                    <li>Guides molecules toward desired properties by curating a property-aware dataset, which integrates preference data.</li>
                    
                    <li>Refines the alignment and generation process through Direct Preference Optimization (DPO) to enhance pharmacological property guidance.</li>
                    
                    <li>Achieves state-of-the-art performance on key evaluation metrics within the CrossDocked2020 benchmark, demonstrating its efficacy as a practical tool for SBDD.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>MolChord integrates an autoregressive model (NatureLM) for generating molecules from text, small molecules, and proteins, alongside a diffusion-based encoder for structural alignment. It refines this process by curating a property-aware dataset incorporating preference data and applies Direct Preference Optimization (DPO) to guide molecule design toward specific pharmacological properties.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The MolChord approach achieved state-of-the-art performance on critical evaluation metrics within the CrossDocked2020 benchmark, significantly improving structure-sequence alignment and property-guided drug generation compared to existing methods.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By enhancing the precision and efficiency of drug candidate generation, MolChord could significantly accelerate early-stage drug discovery, reduce the time and cost associated with identifying promising compounds, and ultimately contribute to the faster development of more targeted and effective therapies for a wide range of diseases.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly mentioned in the abstract.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not explicitly mentioned in the abstract, beyond implying its potential as a practical tool for SBDD.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Structural Biology</span>
                    
                    <span class="tag">Computational Biology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Structure-based Drug Design (SBDD)</span>
                    
                    <span class="tag tag-keyword">Protein-Guided Drug Design</span>
                    
                    <span class="tag tag-keyword">MolChord</span>
                    
                    <span class="tag tag-keyword">NatureLM</span>
                    
                    <span class="tag tag-keyword">Diffusion Model</span>
                    
                    <span class="tag tag-keyword">Direct Preference Optimization (DPO)</span>
                    
                    <span class="tag tag-keyword">Multi-modal Alignment</span>
                    
                    <span class="tag tag-keyword">Drug Discovery</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Structure-based drug design (SBDD), which maps target proteins to candidate
molecular ligands, is a fundamental task in drug discovery. Effectively
aligning protein structural representations with molecular representations, and
ensuring alignment between generated drugs and their pharmacological
properties, remains a critical challenge. To address these challenges, we
propose MolChord, which integrates two key techniques: (1) to align protein and
molecule structures with their textual descriptions and sequential
representations (e.g., FASTA for proteins and SMILES for molecules), we
leverage NatureLM, an autoregressive model unifying text, small molecules, and
proteins, as the molecule generator, alongside a diffusion-based structure
encoder; and (2) to guide molecules toward desired properties, we curate a
property-aware dataset by integrating preference data and refine the alignment
process using Direct Preference Optimization (DPO). Experimental results on
CrossDocked2020 demonstrate that our approach achieves state-of-the-art
performance on key evaluation metrics, highlighting its potential as a
practical tool for SBDD.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>21 pages</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>